ThinkEquity Starts Corcept Therapeutics (CORT) at Buy

June 29, 2012 7:17 AM EDT Send to a Friend
Get Alerts CORT Hot Sheet
Price: $1.85 +2.21%

Rating Summary:
    5 Buy, 3 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 18 | New: 13
Trade CORT Now!
ThinkEquity initiates coverage on Corcept Therapeutics (NASDAQ: CORT) with a Buy. PT $7.00.

For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.

Shares of Corcept Therapeutics closed at $4.29 yesterday, with a 52 week range of $2.50-$4.90.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

New Coverage

Related Entities

ThinkEquity

Add Your Comment